(Q34621494)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20628837%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

review article

1 reference

title

Evidence-based management of statin myopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20628837%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20628837%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Charles R Harper

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20628837%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

1 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20628837%20AND%20SRC:MED&resulttype=core&format=json

Current Atherosclerosis Reports

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20628837%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20628837%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20628837%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

322-330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20628837%20AND%20SRC:MED&resulttype=core&format=json

Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance

7 February 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11883-010-0120-9

Colesevelam hydrochloride-ezetimibe combination lipid-lowering therapy in patients with diabetes or metabolic syndrome and a history of statin intolerance

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11883-010-0120-9

Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs

21 January 2018

1 reference

12 December 2020

Mechanistic studies on metabolic interactions between gemfibrozil and statins

1 reference

12 December 2020

High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors

1 reference

12 December 2020

Benefit versus risk in statin treatment

1 reference

12 December 2020

Managing statin myopathy

1 reference

12 December 2020

Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y.

1 reference

12 December 2020

Expanding Statin Use to Help More At-Risk Patients Is Causing Financial Heartburn

1 reference

12 December 2020

Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study

1 reference

12 December 2020

Benefit-risk assessment of Rosuvastatin 10 to 40 milligrams

1 reference

12 December 2020

ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins

1 reference

12 December 2020

Toward "pain-free" statin prescribing: clinical algorithm for diagnosis and management of myalgia.

1 reference

12 December 2020

Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.

1 reference

12 December 2020

Effect of coenzyme q10 on myopathic symptoms in patients treated with statins

1 reference

12 December 2020

Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle

1 reference

12 December 2020

1 reference

12 December 2020

3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation Inhibitors Induce Apoptosis of Vascular Smooth Muscle Cells in Culture

1 reference

12 December 2020

Statin-induced apoptosis and skeletal myopathy

1 reference

12 December 2020

Statin safety: a systematic review

1 reference

12 December 2020

Myotoxicity associated with lipid-lowering drugs

1 reference

12 December 2020

Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats

1 reference

12 December 2020

Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients

1 reference

12 December 2020

Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin

1 reference

12 December 2020

Managing dyslipidemia in chronic kidney disease.

1 reference

12 December 2020

Molecular clues into the pathogenesis of statin-mediated muscle toxicity

1 reference

12 December 2020

Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro

1 reference

12 December 2020

The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis

1 reference

12 December 2020

Association between statin-associated myopathy and skeletal muscle damage

1 reference

12 December 2020

Lipid-Lowering Drugs and Risk of Myopathy: A Population-Based Follow-Up Study

1 reference

12 December 2020

Clinical characterization and molecular mechanisms of statin myopathy

1 reference

12 December 2020

Effectiveness of statin therapy in adults with coronary heart disease.

1 reference

12 December 2020

Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction

1 reference

12 December 2020

Genetic risk factors associated with lipid-lowering drug-induced myopathies

1 reference

12 December 2020

Low myopathy rates associated with statins as monotherapy or combination therapy with interacting drugs in a group model health maintenance organization

1 reference

12 December 2020

The role of coenzyme Q10 in statin-associated myopathy: a systematic review

1 reference

12 December 2020

High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial

1 reference

12 December 2020

Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia.

1 reference

12 December 2020

Myopathy and rhabdomyolysis with lipid-lowering drugs

1 reference

12 December 2020

Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans

1 reference

12 December 2020

Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients

1 reference

12 December 2020

Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins

1 reference

12 December 2020

Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial

1 reference

12 December 2020

Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.

1 reference

12 December 2020